[HTML][HTML] Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer …

EA Mittendorf, GT Clifton, JP Holmes, E Schneble… - Annals of oncology, 2014‏ - Elsevier
ABSTRACT Background E75 (nelipepimut-S) is a human leukocyte antigen (HLA)-A2/A3-
restricted immunogenic peptide derived from the HER2 protein. We have conducted phase …

Targeting tumor vasculature with TNF leads effector T cells to the tumor and enhances therapeutic efficacy of immune checkpoint blockers in combination with …

AR Elia, M Grioni, V Basso, F Curnis… - Clinical Cancer …, 2018‏ - aacrjournals.org
Purpose: Irregular blood flow and endothelial cell anergy, which characterize many solid
tumors, hinder tumor infiltration by cytotoxic T lymphocytes (CTL). This confers resistance to …

The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape

B Seliger, C Massa - Frontiers in immunology, 2013‏ - frontiersin.org
Dendritic cells (DC) play a central role in the regulation of the immune responses by
providing the information needed to decide between tolerance, ignorance, or active …

Inefficacy of therapeutic cancer vaccines and proposed improvements. Casus of prostate cancer

JJL Jacobs, C Snackey, AA Geldof… - Anticancer …, 2014‏ - ar.iiarjournals.org
Prophylactic vaccination is arguably the most effective medical preventative method. After
local inoculation, vaccines induce antigen-specific systemic immunity, protecting the whole …

Dendritic cell regulation of NK‐cell responses involves lymphotoxin‐α, IL‐12, and TGF‐β

D Sarhan, M Palma, Y Mao, L Adamson… - European journal of …, 2015‏ - Wiley Online Library
Dendritic cell (DC) vaccines induce T‐cell responses in cancer patients. However, there is a
paucity of data regarding the role of DC vaccines in sha** natural killer (NK) cell …

Prophylactic dendritic cell-based vaccines efficiently inhibit metastases in murine metastatic melanoma

OV Markov, NL Mironova, SV Sennikov, VV Vlassov… - PLoS …, 2015‏ - journals.plos.org
Recent data on the application of dendritic cells (DCs) as anti-tumor vaccines has shown
their great potential in therapy and prophylaxis of cancer. Here we report on a comparison of …

Induction of T-cell memory by a dendritic cell vaccine: a computational model

F Pappalardo, M Pennisi, A Ricupito, F Topputo… - …, 2014‏ - academic.oup.com
Motivation: Although results from phase III clinical trials substantially support the use of
prophylactic and therapeutic vaccines against cancer, what has yet to be defined is how …

Immuno-kinetics of immunotherapy: dosing with DCs

E Köse, S Moore, C Ofodile… - Letters in …, 2017‏ - lettersinbiomath.org
Therapeutic vaccines play a large role in the cast of immunotherapies that are now an
essential component in most cancer treatment regimes. The complexity of the immune …

Efficacy of Dendritic Cell-Based Immunotherapy Produced from Cord Blood in vitro and in a Humanized NSG Mouse Cancer Model

G Liu, X Fan, Y Cai, Z Fu, F Gao, J Dong, K Li… - Immunotherapy, 2019‏ - Taylor & Francis
Aim: To produce dendritic cells (DCs) from CD34+ stem cells from cord blood and explore
their prophylactic and curative effect against tumors by vaccinating humanized NSG mice …

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice

R Mikyskova, M Indrova, I Stepanek, I Kanchev… - …, 2017‏ - Taylor & Francis
Dendritic cell (DC)-based vaccines pulsed with high hydrostatic pressure (HHP)-inactivated
tumor cells have recently been shown to be a promising tool for prostate cancer …